ReviewDiscover oncology2025

PD-1/PD-L1 blockade therapy with atezolizumab: a new paradigm in the treatment of non-small cell lung cancer (NSCLC).

Samaneh Moradi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.